OTC Challenge: August Series, 2017 (Super Winner)


Super Winner for OTC Challenge: August Series, 2017





B.R.SINGH is our Super Winner for August Series OTC Challenge. He is Managing Partner of Break Thru Lab resources since 1997, also venture into chemicals Exports through Rishima Exim Venture Inc. since 2014. He did his Graduation in Economics and Post Graduation in Law & PGD in PM & IR from NIPM and PGD in HRD from M.S. University.

He is into financial market since 2006. He is Mechanical Trader and has his own trading system. He is very much active trader in future and cash segment since last 7 years. He also trades Option to hedge his future positions.

He won Two Days Options Strategy Trading Workshop (Weekend) that he can attend in the month of November or December 2017. Meanwhile, we have shared OpStrater package along with study material to get prepared for workshop.


Congratulations B.R.SINGH!!!



2 comments:

  1. A great call for people out there looking for such opportunities. Thank you providing the information in such great details, a very informative post for people interested

    ReplyDelete
  2. Hello everyone, it’s my first go to see at this web site, and article
    is in fact fruitful in favor of me, keep up posting such content.Best CV Writing Service

    ReplyDelete

Note: Only a member of this blog may post a comment.

SEBI Registered Research Analyst Name: Santosh Kumar Karmraj Pasi

SEBI Research Analyst Registration No.: INH000009533

BSE Enlistment No.: 5554

Email: santoshpasi@yahoo.com

Telephone: +91.98202.00550

Address: Flat D-303, Akar Pinnacle, Near BMC Dattapada School,, Dattapada Road, Dattapada, Borivali (E), MUMBAI, MAHARASHTRA, 400066

Warning: "Investment in securities market are subject to market risks. Read all the related documents carefully before investing."

Disclaimer: "Registration granted by SEBI, enlistment of RA with Exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."

"The securities quoted are for illustration only and are not recommendatory."

Pages